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Surrogate Pregnancy After Prenatal
Diagnosis of Spina Bifida
Lynnette J. Mazur, MD, MPH,a Mary Kay Kisthardt, JD, LLM,b Helen H. Kim, MD,c Laura M. Rosas, BBA,a John D. Lantos, MDd

Some pregnancies today involve infertile individuals or couples who
contract with a fertile woman to carry a pregnancy for them. The woman
who carries the pregnancy is referred to as a “gestational carrier.” The use
of such arrangements is increasing. Most of the time, these arrangements
play out as planned; sometimes, however, problems arise. This article
discusses a case in which a fetal diagnosis of spina bifida led the infertile
couple to request that the gestational carrier terminate the pregnancy, and
the gestational carrier did not wish to do so. Experts in the medical and
legal issues surrounding surrogacy discuss the considerations that should
go into resolving such a conflict.

The number of births that follow
surrogacy arrangements involving
a gestational carrier is at an all-time
high in the United States.1 Typically,
in these cases, an infertile individual
or couple makes an arrangement with
a woman who is capable of carrying
a pregnancy to bear a child and then
turn that child over at birth to the
infertile individual or couple. In some
cases, the egg and sperm come from
the contracting couple. In other cases,
the egg comes from an oocyte donor
or, less often, from the gestational
carrier (an arrangement called
traditional surrogacy). The parties
to such arrangements sign legal
contracts. Sometimes, money changes
hands; in other cases, the surrogacy
is altruistic. All such arrangements
are fraught with potential conflicts.
When such contracts arise, the courts
may be called upon to resolve them. In
this Ethics Rounds, we present a case
of surrogacy in which the fetus was
diagnosed with spina bifida (SB) and
analyze the conflicts that followed.

THE CASE
A 32-year-old G3P2 female patient
presented for a prenatal pediatric

consultation at 21 3/7 weeks’
gestation. The pregnancy was the
result of in vitro fertilization (IVF);
the patient was a surrogate. The
intended parents lived in Europe.
Because surrogacy was illegal in
their country, an American lawyer
initiated the contract between the
couple and the surrogate. After a few
months of legal, psychological, and
medical preparations, an egg from
an anonymous donor was fertilized
with the father’s sperm, and the
resultant embryo was implanted in
the surrogate. The agreement was for
the intended parents to take the child
back to their country; the surrogate
would have no future rights or contact
with the child.
An ultrasound showed a male fetus
with SB at the second sacral level. No
hydrocephalus or other anomalies
were noted. Shortly after the doctor
introduced herself to the pregnant
woman, she said that she was not
the mother. She called herself "the
toaster.” She suggested calling the
intended parents to discuss SB. The
father spoke some English; his wife
did not. Over the course of 45 minutes,
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the doctor explained the expected
challenges that their son may
develop.
In general, the disabilities depend
on the level of the lesion; the higher
the defect, the more adverse the
outcomes. Neurologically, most
children with SB have an IQ in the
normal range but many having
learning difficulties. In this case,
because of the low level and the
absence of hydrocephalus, the need
for a ventriculoperitoneal shunt
was considered unlikely. However,
because sacral nerves are needed
for bladder and bowel function, the
infant would be at risk for recurrent
urinary tract infections and declining
renal function. Daily intermittent
bladder catheterizations and
medications to prevent leaking might
be needed. Sensory deficits in the
genital area may require medications
for future erectile dysfunction. In
addition, constipation is a common
problem and can lead to leaking
of stool, recurrent urinary tract
infections, pressure ulcers, and shunt
malfunction. Orthopedically, the
muscles innervated by the nerves
below the defect will be weak.
Children with sacral defects usually
walk without assistive devices, but
orthotic devices for ankle stability
and protection of the feet will likely
be needed. Sensory deficits place
him at risk for pressure ulcers and
fractures.2
After explaining these challenges,
the couple stated that they did not
want to raise a defective child. They
preferred an abortion but would
consider in utero correction. The
surrogate objected to a termination
and because of the low level of
the lesion, she was not a surgical
candidate.3,4

Lynnette J. Mazur/Laura M. Rosas
Comments
The first successful surrogate
pregnancy (ie, the carrying of a
pregnancy for other intended
parents) occurred in 1985. Surrogacy

can be traditional or gestational.
In traditional surrogacy (natural,
partial, or straight surrogacy), the
surrogate is impregnated naturally or
artificially with the intended father’s
sperm, and the child is genetically
related to both the surrogate and
the father. In a gestational surrogacy
(full, host, or IVF surrogacy), the
embryo, resulting from the intended
father’s sperm and an egg donor,
is implanted in the surrogate and
is biologically unrelated to her.
Either form can be commercial (the
surrogate is compensated by the
commissioners) or altruistic (the
surrogate has reasons other than
financial gain). Our patient was a
commercial surrogate.
Surrogacy is especially complex
because the interests of the intended
parents, the surrogate, her spouse
(if she has one), and the future child,
may differ. Cases with international
contracts have unique complexities.
When unexpected fetal defects are
encountered, both parties may
face ethical, legal, medical, moral,
and practical dilemmas. Given the
time limitations on a postviability
termination or a late-term abortion
(after 20 weeks’ gestation) and
for fetal surgery (before 26 weeks’
gestation), a timely legal settlement
may not be possible.
How do the involved parties address
these issues? By the nature of the
agreement, both parties voluntarily
accepted some restrictions on their
autonomy. It follows that neither
party should unilaterally change their
mind after the start of the pregnancy.
In addition, because the surrogate
freely entered into the contract, she
accepted other restrictions to her
autonomy. She is expected to follow
a healthy lifestyle and attend regular
physician visits. Although she has
a prima facie obligation to accept
the advice of the obstetrician that
will ensure the best outcome for
herself and the child, she cannot be
forced to accept a cesarean delivery
(CD) for a child with SB. Also, given

the principle of autonomy, it is
impossible either to prevent her or
to force her to have an abortion.5 She
retains the right to confidentiality
and the right to determine what
information about the pregnancy the
health care providers can share with
the commissioner(s).
In view of the fetus’ birth defect,
both parties questioned the
agreement. Each wanted to do
what was in their best interest, the
principle of ethical egoism. The
surrogate wanted to continue the
pregnancy, and the couple did not
want a child with SB. However,
given their conflicting desires,
who should make the decision?
A termination may adversely affect
the surrogate’s health, her ability
to care for her current children, or
her future pregnancies. It may be
against her beliefs or it may be too
late in the pregnancy to perform.
Accordingly, adoption would be an
option; the surrogate could follow
her conscience, and the couple would
not have to raise the child. Payments
and/or reimbursements for both
the surrogate’s and the infant’s
medical expenses would need to be
determined.
Other important questions remain.
For the surrogate’s family, what
are the psychological consequences
for the surrogate’s family of
relinquishing their child/sibling?
Our patient stated that her own
children were confused about her
pregnancy. One afternoon her
daughter’s kindergarten teacher
asked for clarification of her
daughter’s statement “My mommy
is pregnant but he is not our
brother.” What are the consequences
if the surrogate keeps in contact
with the resulting family? For the
commissioning parents, what are the
legal consequences of breaking the
contract? What is the risk of rejection
or risk of the child being the object of
conflict between the parties? What
information is shared with the child
as he matures? For the egg donor,
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is there a duty or a responsibility
to find and inform her about her
future risk for children with SB?
This knowledge may lead her and
her female relatives to receive
folic acid supplementation before
becoming pregnant in an effort to
prevent SB. For the child with SB,
what is his fate and who will pay his
medical expenses? For the remaining
embryos, what is their fate? For the
health care provider counseling the
surrogate and the commissioning
parents, how does he or she maintain
neutrality when presenting both
parties with difficult choices?

Mary Kay Kisthardt Comments
This case raises complex ethical
issues and even more complicated
legal issues. I am a law professor and
thus will focus primarily on the legal
issues.
The development of the law related
to enforcement of surrogacy
contracts has had a tortured course.6
The complexity relates both to the
complicated nature of the underlying
issues but also to the fact that, in
the United States, legal rules in
this domain are made by the states
and thus vary from state to state.
Many states accept the notion of
“intentional parenthood” and bestow
rights to the legally recognized
parents even if they are not the
biological (or gestational) parents.7
However, parents do not always get
the right to make decisions regarding
their children, especially where the
exercise of those rights conflicts with
the rights of another adult who might
be considered to be a parent or with
somebody’s perception of what is in
the best interest of the child.
There is an obvious legal deficiency
here: the absence of any language
in the contract regarding decisions
during pregnancy. Most surrogacy
contracts now contain clauses related
to selective reduction in the case of a
multifetal pregnancy or abortion in
the event of a potential birth defect.8
Courts do not have the authority

to require a gestational surrogate
to abort a fetus at the request of
the biological parents. A contract
with such a clause would thus be
unenforceable.9 Contracts could
raise the issue, however, to begin a
discussion between the surrogate
and the intended parents to gauge
their ability to agree on a decision
when a change of circumstances
occurs. That is not to say that
any pre-pregnancy consensus
will necessarily continue once a
pregnancy has begun (I believe that
most women who have carried a
child would agree that there is a
fundamental difference between an
imagined fetus and the one you are
actually carrying in your womb), but
it is a good starting point.
However, in this case, we are left
with the need to make a decision
when those conversations have not
taken place. The key question is how
to facilitate those conversations now
that the parties are facing significant
time pressure as well as possible
language and cultural barriers.
The intended parents’ desire to
consider a “correction” may indicate
that there may be room for further
consideration, especially in light of
the fact that the surrogate will retain
the right to carry the pregnancy
to term. If we start with that
assumption, the focus can then shift
away from the immediate decision
to the long-term consequences of it.
If the child is carried to term, who
will be responsible for his care?
Does the gestational mother intend
to raise him? Most gestational
surrogates are without the resources
to raise another child. If she does,
the courts will undoubtedly require
financial support from the intended
parents. What if she wishes to raise
him but the intended parents wish
to place him for adoption, thereby
terminating both their rights
and their duty to support? As the
legal parents of the child, they are
presumptively entitled to do so.
These questions should all be part

of the discussion because they help
to inform the decision. I do not think
that there is a single right answer to
these questions. Instead, I think there
is a need for open, honest discussion
that will, as its goal, help the
parties involved come to a mutually
agreeable plan.
To me, this case is ideal for a
mediation process (again revealing
my professional bias) because
these implications can only be fully
explored through conversation.
As a mediator, I would hope to not
only allow the parties to consider
the legal implications but to begin
to turn the discussion to a common
goal of advancing the best interest
of the child. How do the intended
parents view a child with health
issues? Is their desire to terminate
based on a concern about their
ability to meet his needs both
financially and otherwise? Is their
sense of disappointment in not
having a “normal” long-desired child
influencing their judgment? Is the
gestational surrogate’s objection to
the abortion a religious one? A moral
one? How does she feel about raising
the child? How will she feel if she
carries the child to term and then is
unable to keep him?
The implications of the decision will
no doubt have lasting effects on all
the parties involved. At a minimum,
they deserve the opportunity to
engage in a meaningful conversation
about them.

Helen H. Kim Comments
In 2012, I experienced “15 minutes
of fame” when I helped “Grandma
to give birth to her grandchild (as
reported by the Today Show).”10 The
intended parent had a hysterectomy
for the treatment of cancer. Her
52-year-old mother carried the
pregnancy. This case was the story of
an altruistic woman who served as
a gestational carrier out of love and
delivered a healthy infant after an
uncomplicated pregnancy.
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In contrast to that heartwarming
story, the present case is
heartbreaking. After birth, it is
possible that the infant will have no
parents. The parties were strangers
who met via a lawyer. They did
not have a preexisting relationship
and most likely never developed a
relationship. They live in different
countries and do not speak the same
language. When an unexpected
pregnancy complication developed,
they disagreed on the best course of
action. After learning that the fetus
has SB, the intended parents no
longer want the infant; they prefer
that the pregnancy be terminated.
The gestational carrier, however,
objects to pregnancy termination, an
invasive procedure, and thus does
not give her consent.
A little history might put this case
in context. In 1978, the birth of
Louise Brown, the first human infant
born after IVF, proved that viable
embryos could be generated in the
laboratory.11 Although IVF was
initially developed to treat tubal
infertility, the ability to generate
embryos outside the body allowed
for third-party reproduction, using
oocyte donors and gestational
carriers. By synchronizing the
uterine lining with the development
of the embryo, embryos generated
with eggs from 1 woman could be
implanted in the uterus of another.
The first pregnancy using donor
oocyte was reported in 1984,12
followed in the next year by the first
pregnancy in a gestational carrier.13
Between 1999 and 2013, there
were 1 664 844 cycles of assisted
reproduction in the United States that
resulted in embryo transfer, of which
30 927 (1.9%) used a gestational
carrier.14 Now, with gestational
surrogacy, patients who are unable
to carry a pregnancy are able to have
genetic children. Indications for
gestational surrogacy include lack of
normal uterus (due to hysterectomy,
uterine abnormality, or lack of female
partner) or the presence of a serious

medical condition that would be
a contraindication to pregnancy.
In addition, because gestational
surrogacy is illegal in some countries,
an increasing number of patients
are seeking this service in the
United States. In 2013, 18.5% of
US gestational carrier cycles were
performed for non-US residents (in
contrast to 9.5% in 1999).
The use of gestational carriers has
always been controversial due to
concerns regarding commodification
of the body or infant selling, but for
many, gestational surrogacy is the
only option for genetic parenthood.
Generally, gestational carrier cycles
are very successful. As reported by
Perkins et al,14 among US clinics
reporting to the Centers for Disease
Control and Prevention (CDC)
between 2009 and 2013, gestational
carrier cycles had higher rates of live
births (41.5%) than nongestational
carrier IVF cycles (36.5%).
Consequently, the use of gestational
carriers is becoming more common
and more widespread. The number of
gestational carrier cycles reported to
the CDC increased from 727 cycles in
1999 to 3432 cycles in 2013. During
the same time period, the number
of clinics performing gestational
surrogacy increased from 167 in
1999 to 324 in 2013. By 2013, 85%
of the clinics reporting to CDC offered
gestational carrier treatment.
With the increased prevalence of
gestational surrogacy, efforts are
needed to avoid heartbreaking
situations such as the one described
in the present case. The American
Society for Reproductive Medicine
(ASRM) practice committee has
recommendations for practices
utilizing gestational carriers.15 These
include psychosocial consultation
for both gestational carriers and
intended parents. Recommended
counseling topics include pregnancy
scenarios, such as multifetal
pregnancy reduction, prenatal
diagnostic testing, and elective
termination. Discussions between

the intended parents and gestational
carrier should occur before embryo
transfer to confirm that their values
are aligned. Although the human
response to a particular situation
is never completely predictable,
it is hoped that adequate prepregnancy counseling and discussion
would allow intended parents and
gestational carriers to prepare for
various pregnancy outcomes and
develop matching expectations.
Unfortunately, such preventive
measures do not always work.
So, how should the present case
be resolved? Because abortion is
illegal after 24 weeks’ gestation, a
decision to terminate the pregnancy
would have to be made quickly.
Pragmatically, if an agreement is not
reached, the infant will be born.
Deciding to terminate a (previously)
desired and planned pregnancy is
always difficult—and is even more
difficult with a third party. When
multiple parties, from different
backgrounds, are involved in 1
pregnancy, there is great potential
for conflict. The best outcome would
be for the couple and the gestational
carrier to come to an agreement,
but it will be difficult for them to
build rapport and have a meaningful
discussion when they are not in the
same room and do not speak the
same language, a scenario which is
not uncommon.
Even if the gestational carrier had
previously agreed to pregnancy
termination, she may feel
differently now. Her refusal to
have an abortion may be a breach
of the surrogacy agreement with
financial implications, but she
cannot be forced to undergo an
invasive medical procedure without
her consent. Both the American
Congress of Obstetricians and
Gynecologists16 and the ASRM17
support the gestational carrier’s right
to “autonomous decision-making.”
The ASRM ethics committee opinion
states “the carrier has the ultimate
authority about any procedures on
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her body and cannot be compelled to
submit to a procedure regardless of
the contract.”15
Thus, although this case is complex,
the right answer is clear. The
pregnancy should not be terminated
without the consent of the gestational
carrier. If the contracting couple will
not take the infant, the infant will
need to be put up for adoption.

whether they are capable of raising
a child or whether they truly desire
to have one. With surrogacy, as with
adoption, the law is called upon to
attempt to define the responsibilities
that parenthood entails. But the
law is a blunt instrument. It is not
surprising that dilemmas sometimes
arise in these complicated gestational
arrangements. It is, perhaps, more
surprising that they do not arise
more often.

RESOLUTION OF THE CASE
This case had a happy ending. The
surrogate agreed to give birth to the
infant via cesarean delivery, and the
intended parents decided to keep
the infant. The defect was surgically
repaired shortly after birth.
In general, surrogacy agreements
are binding for the commissioning
parents in cases of birth defects or
a multiple pregnancy. Regardless
of what was stipulated in the
agreement, the child or children
born are their responsibility.
However, timely enforcement and
legal arguments may leave the child
without permanent placement while
awaiting resolution.
In 2013, ~67 000 infants were
born in the United States through
IVF. About 2% of those (ie, >1300
births) were through surrogacy
arrangements. Even if 99% of
cases go well, there will still be
many cases that raise legal and
ethical controversies. Health care
providers need to know not just the
medical issues associated with such
pregnancies but the legal and ethical
ones as well.18,19

JOHN D. LANTOS COMMENTS
Surrogacy arrangements involving
gestational carriers have shed a new
light on an old dilemma about the
responsibilities that go along with
bringing a child into the world. There
is no licensing agency for parenthood.
For anybody with the natural ability
to have a child, they can have one

ABBREVIATIONS
ASRM: American Society for
Reproductive Medicine
CDC: Centers for Disease Control
and Prevention
IVF: in vitro fertilization
SB: spina bifida
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